Rhythm Pharmaceuticals Inc (NAS:RYTM)
$ 55.59 -0.95 (-1.68%) Market Cap: 3.47 Bil Enterprise Value: 3.14 Bil PE Ratio: 0 PB Ratio: 308.96 GF Score: 58/100

Rhythm Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 08, 2022 / 06:00PM GMT
Release Date Price: $4.15 (+10.08%)
Operator

Good afternoon. Hello, and welcome to the Annual Meeting of Stockholders of Rhythm Pharmaceuticals, Inc. Please note that today's meeting is being recorded. (Operator Instructions) It is now my pleasure to turn today's meeting over to David Meeker, Chairman of the Rhythm Board of Directors, President and Chief Executive Officer.

David P. Meeker
Rhythm Pharmaceuticals, Inc. - Chairman, President & CEO

Good afternoon. I am David Meeker, Chairman of the Board of Directors, President and Chief Executive Officer of Rhythm Pharmaceuticals and the Chairperson of today's meeting. Let me take this opportunity to welcome all those attending our 2022 Annual Meeting of Stockholders, which we are holding virtually.

Before the meeting is called to order, I'd like to introduce you to the other members of the Board and officers of the company who are on the webcast today: Camille Bedrosian, Jennifer Good, Christophe Jean, David McGirr and Lynn Tetrault. Ed Mathers is joining us by phone, and Stuart Arbuckle could not be with us today. From the company, we also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot